Novo Nordisk has published its annual report for 2025

Company Overview - Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, focusing on defeating serious chronic diseases, particularly diabetes [2] - The company employs approximately 68,800 people across 80 countries and markets its products in around 170 countries [2] - Novo Nordisk's B shares are listed on Nasdaq Copenhagen, while its American Depositary Receipts (ADRs) are listed on the New York Stock Exchange [2] Recent Developments - Novo Nordisk has issued its 2025 annual report, which is available for public access [1]